On the surface, this sounds ridiculously dirty: Pfizer is about to start selling VIAGRA FOR CHILDREN.

–But fortunately, it’s not to help kids with sexual dysfunction. Since Viagra modifies a person’s blood flow, it’s actually really useful in fighting a lung disease called pulmonary arterial hypertension, which affects about 600 kids a year.

–Sounds great, right? A nice humanitarian gesture . . . using the world’s most famous sexual aide to help ease the dizziness, fatigue and severe pain that come with this disease. Well . . . let’s circle back around to it being kinda dirty again.

–Pfizer isn’t doing this out of the goodness of its heart. In fact, when the FDA asked them to tweak Viagra to make it suitable for treating kids, they initially said NO . . . since they couldn’t make enough of a profit helping ONLY 600 sick kids a year.

–So the FDA made a deal with them. The patent for Viagra expires in 2012. That means in less than two years it’s open season . . . generic manufacturers can make and sell it, and Pfizer’s Viagra profits will be exponentially slashed.

–But the FDA said they’d EXTEND the Viagra patent by six months . . . giving Pfizer six more months of profit, which could be worth more than $1 BILLION . . . if Pfizer tweaks Viagra to make it suitable for treating kids’ lung problems.

–Pfizer agreed, and now that there’s profit to be had, the Viagra for Children should hit the market soon.